Our global D&I strategy shows that we are all accountable to make Diversity & Inclusion a part of our DNA and unlock its power to serve patients.
Our global D&I strategy shows that we are all accountable to make Diversity & Inclusion a part of our DNA and unlock its power to serve patients.
At Pfizer, we strive to attract the best and brightest talent; and ensure that each colleague can do their best work in an environment and culture where diversity and inclusion (D&I) are championed around the world. We find inspiration for the work we do within the diverse communities of patients we serve.
Video Player is loading.
Pfizer senior leaders have a candid conversation about Pfizer’s continued commitment to diversity and inclusion
DATA & METRICS
33%
In 2019, representation of women at the VP level and above was 33% globally
47%
By 2025, Pfizer aims to increase representation of women from 33% to 47% globally
19%
In 2019, representation of minorities at the VP level and above was 19% in the U.S.
25%
By 2025, Pfizer aims to increase representation of minorities from 19% to 25% in the U.S.
CRG's & ENGAGEMENT
14,000+
More than 15% of our workforce, 14,000+ colleagues, are actively engaged in D&I efforts through a global network of 125+ Colleague Resource Groups (CRGs)
PARTNERSHIP / RECOGNITION
Equity & Inclusion
Pfizer Chairman and CEO, Dr. Albert Bourla sits on Catalyst’s Board of Directors and is one of their CEO Champions for Change. Pfizer also sponsored Catalyst’s Equity and Inclusion research
Gender Parity Collaborative
Founding member of Healthcare Businesswomen’s Association Gender Parity Collaborative to advance initiatives fostering measurable gender parity progress in the industry
LGBTQ Equality
Received a perfect score of 100% on the Human Rights Campaign2019 Corporate Equality Index and designation as a Best Place to Work for LGBTQ Equality for the 16th straight year
Underrepresented Talent
Established enterprise partnerships with the Hispanic Association on Corporate Responsibility and Disability:IN to enhance engagement of underrepresented talent and benchmark our progress
Center for Talent Innovation
Sponsored research with Center for Talent Innovation titled Being Black in Corporate America: An Intersectional Exploration
CLINICAL TRIAL DIVERSITY
49
Clinical studies committed to tracking diversity
64%
of 2019 study starts are tracking diversity (Phase 2 & 3)
2
Investigator training sessions completed, with diversity as a standalone module (with 2 additional sessions scheduled before the end of the year)
SUPPLIER DIVERSITY
$4.1 billion
Over the past 5 years, Pfizer spent $4.1 billion with certified Small Business Enterprises (SBE) suppliers
$3.5 billion
Over the past 5 years, Pfizer spent $3.5 billion with certified Minorty Women Business Enterprises (MWBE) suppliers
3,000
During the same time period, we have partnered with over 3,000 SBE suppliers
1,000
During the same time period, we have partnered with over 1,000 MWBE suppliers
7
Formally engaged in seven mentorships with diverse suppliers across various categories, including Human Resources, Business Technology and Marketing
20+
Launched category Matchmaking days, hosting 20+ diverse suppliers across the categories of Marketing Communications and Professional Services, creating over 100 touchpoints
3 consecutive years
Received the Best of the Best Award, a national award for the past 3 yearsSee here
10+ consecutive years
Recognized as a Top Corporation Award for 10+ yearsSee here
Women Business Enterprises
Invested in the development of woman business enterprises by hosting an internal Pfizer event for local women-owned businesses, titled “Female Founders,” to showcase Pfizer’s partnership with women-owned businesses
Corporates Opportunity Award
Received the Corporate Opportunity Award for the first time from Women’s Presidents Organization (WPO) in New York
Dr. Freda Lewis Hall
was elected Chair of the Board of Directors for the National Minority Supplier Development Council (NMSDC). She was elected to a new two-year term during the board’s spring meeting in New York on May 17, 2019.See here
2019 Global D&I Summit:
Pfizer hosted the first-ever global broadcast of its annualD&I Summit, linking the company’s Diversity & Inclusion strategy to Pfizer’s new Values, with a focus on Equity. The Summit included Pfizer’s Chairman and CEO, Dr. Albert Bourla and Chief Human Resources Officer Dawn Rogers who shared the results ofPfizer’s first global pay equity study, and members of Pfizer’s Diversity & Inclusion Governance Council.
.jpg)
.jpg)
Share this page
